1-3 of 3
Maureen Reiner, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mobilization of Stem Cells with DT-PACE Plus Pegfilgrastim vs. DT-PACE Plus Filgrastim in Previously Treated MM Patients.

Guido Tricot, MD, PhD, Maureen Reiner, MS, Michael Burns, BS, Maurizio Zangari, MD, Frits van Rhee, MD, PhD, Bart Barlogie, MD, PhD, Michele Cottler-Fox, MD
Journal: Blood
Blood (2005) 106 (11): 1972.
https://doi.org/10.1182/blood.V106.11.1972.1972
Published: 2005
Journal Articles

Melphalan 200mg/m 2 (MEL 200) and MEL 140/DT-PACE Are Equally Effective in Multiple Myeloma (MM), While the Latter Is Less Toxic.

Guido Tricot, MD, PhD, Maureen Reiner, MS, Maurizio Zangari, MD, Frits van Rhee, MD, PhD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 839.
https://doi.org/10.1182/blood.V106.11.839.839
Published: 2005
Journal Articles

The Time Required To Achieve Complete Remission (CR) during Intensive Therapy on Total Therapy 2 Does Not Influence Event Free Survival (EFS), While Improvement in Quality of Response with Ongoing Treatment Clearly Does.

Guido Tricot, MD, PhD, Maureen Reiner, MS, Maurizio Zangari, MD, Frits van Rhee, MD, PhD, Elias Anaissie, MD, Teresa Milner, BS, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1157.
https://doi.org/10.1182/blood.V106.11.1157.1157
Published: 2005